| Dr Michael Norbert Mangold, MD | |
|
120 N Main St, #120, West Bend, WI 53095-3376 | |
| (262) 338-8100 | |
| (262) 338-0405 |
| Full Name | Dr Michael Norbert Mangold |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 120 N Main St, West Bend, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588685895 | NPI | - | NPPES |
| 31843700 | Medicaid | WI | |
| 000054100 | Other | WI | MEDICARE, WPS, FQHC |
| 521833 | Other | WI | MEDICARE FQHC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 32859 (Wisconsin) | Secondary |
| 207Q00000X | Family Medicine | 32859-20 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Norbert Mangold, MD 120 N Main St, #120, West Bend, WI 53095-3376 Ph: (262) 338-8100 | Dr Michael Norbert Mangold, MD 120 N Main St, #120, West Bend, WI 53095-3376 Ph: (262) 338-8100 |
News Archive
GlaxoSmithKline announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] be given to girls and young women to protect against cervical pre-cancers and cervical cancer caused by oncogenic HPV 16 and 18.
EDDA Technology announced today that the number of clinical cases evaluated for pre- and post- operative assessment using IQQA-Liver in hospitals has exceeded 1000 examinations, since the first commercial system installation in Q2 2009. EDDA's IQQA-Liver, now marketed worldwide, is a comprehensive workflow solution supporting modern multidisciplinary liver imaging evaluation and management.
UNICEF Executive Director Anthony Lake told reporters on Friday that "more than 300,000 children in the Horn of Africa are severely malnourished 'and in imminent risk of dying' because of drought and famine," the Associated Press/Washington Post reports.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
› Verified 7 days ago
Gary L Preisler, Family Medicine Medicare: Medicare Enrolled Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Deborah S Haas, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Bruce G Griswold, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Anthony S Guthrie, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Daniela Aleman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Kristin Elizabeth Dement, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Gary M Herdrich, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 |